期刊文献+

依那普利对大鼠肾间质纤维化中TGF-β1,p-Smad2/3及Smad7的作用 被引量:3

Effect of enalapril on the expression of TGF-β1,p-Smad2/3 and Smad7 in renal interstitial fibrosis in rats
下载PDF
导出
摘要 目的:观察依那普利对肾间质纤维化大鼠肾组织中TGF-β1,p-Smad2/3及Smad7的影响,探讨依那普利抗肾间质纤维化的作用机制。方法:将30只雌性SD大鼠随机分为假手术组、模型组和依那普利治疗组。对治疗组和模型组大鼠行左侧输尿管结扎术建立单侧输尿管梗阻的动物模型。术后14d处死大鼠,留取梗阻侧肾组织行HE和Masson染色以观察各组大鼠肾组织病理改变,用免疫组织化学方法检测ColⅠ,TGF-β1,p-Smad2/3和Smad7的蛋白水平表达,用RT-PCR方法检测TGF-β1和Smad7mRNA水平表达。结果:模型组肾间质损伤指数、胶原相对面积及间质内ColⅠ表达均较假手术组增高(P<0.01),依那普利治疗后好转。假手术组肾组织TGF-β1蛋白及mRNA表达、p-Smad2/3蛋白表达较低,模型组表达明显增强(P<0.01),依那普利治疗后明显减弱(P<0.01)。假手术组肾组织可见较多的Smad7蛋白及mRNA表达,模型组肾组织Smad7表达明显减弱(P<0.01),依那普利治疗后Smad7表达较模型组增强(P<0.01)。结论:依那普利可以通过影响单侧输尿管梗阻大鼠肾组织中TGF-β/Smads信号通路中的TGF-β1,p-Smad2/3和Smad7而起到抑制纤维化的作用。 Objective To explore the mechanism of enalapril for renal interstitial fibrosis by observing the effect of enalapril on the expression of transforming growth factor-β1 ( TGF-β1 ) , p- Smad2/3 and Smad7 in renal tissuess of unilateral urethral obstruction ( UUO ) rat model. Methods Thirty female Sprague-Dawley (SD) rats were randomly subdivided into a sham-operated group, a model group and an enalapril treated group. UUO model was induced by ligating the left ureter of rats. All rats were sacrificed 14 days after UUO. Pathological changes of the renal tissue were observed by HE and Masson staining, the protein expressions of Collagen Ⅰ(Col Ⅰ) , TGF-β1, p- Smad2/3 and Smad7 were detected by immunohistoehemical staining, and the mRNA expressions of TGF-β1 and Smad7 were detected by RT-PCR. Results The renal interstitial damage index, the relative Collagen area and the expression of Col Ⅰ in the model group significantly increased (P 〈 0.01 ). Enalapril reduced these indexes. The protein and mRNA expressions of TGF-β1 and the protein expressions of p-Smad2/3 were low in the sham-operated group, but were strongly positive in the model group, and enalapril could decrease the expressions of TGF-β1 and p-Smad2/3 ( P 〈 0.01 ). The protein and mRNA expressions of Smad7 in the model group were less than that in the sham-operated group ( P 〈 0.01 ) , and enalapril could improve the expressions of Smad7 ( P 〈 0.01 ). Conclusion Enalapril could inhibit the renal interstitial fibrosis by affecting TGF-β1, p-Smad2/3 and Smad7 of TGF-β/smads pathway in the renal tissues of UUO rats.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2009年第1期27-34,共8页 Journal of Central South University :Medical Science
基金 湖南省自然科学基金(07-JJ3056)~~
关键词 肾间质纤维化 依那普利 转化因子β1 SMAD renal interstitial fibrosis enalapril transforming growth factor-β 1 Smad
  • 相关文献

参考文献16

  • 1Schiffer M, von Gersdorff G, Bitzer M. Smad proteins and transforming growth factor-beta signaling [ J ]. Kidney Int, 2000,77(Suppl 1) : S45-52.
  • 2Hou F F, Zhang X, Zhang G H, et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency [ J]. N Engl J Med,2006,354(2) : 131-140.
  • 3Radford M G Jr, Donadio J V Jr, Bergstralh E J, et al. Predicting renal outcome in IgA nephropathy [ J ] . J Am Soc Nephrol, 1997 , 8 (2) : 199-207.
  • 4Riera M, Torras J, Cruzado J M, et al. The enhancement of endogenous cAMP with pituitary adenylate cyclase-activating polypeptide protects rat kidney against ischemia through the modulation of inflammatory response [ J 1. Transplantation, 2001 ,72 (7): 1217-1723.
  • 5忻菁,顾勇,陈靖,杨海春,林善锬.内皮素受体阻断剂在高血压糖尿病鼠中的肾脏保护作用及其可能机制[J].中华肾脏病杂志,2002,18(2):107-110. 被引量:6
  • 6Ruiz-Ortega M, Ruperez M, Esteban V, et al. Angiotensin Ⅱ: a key factor in the inflammatory and fibrotic response in kidney diseases [ J ] . Nephrol Dial Transplant, 2006 , 21 (1): 16-20.
  • 7Schiffer M, yon Gersdorff G, Bitzer M, et al. Smad proteins and transforming growth factor-beta signaling [ J ]. Kidney Int, 2000,77 ( Suppl 1 ) : S45-52.
  • 8Derynck R, Zhang Y E. Smad-dependent and Smad-independent pathways in TGF-beta family signaling [ J ]. Nature,2003, 425 (6958) : 577-584.
  • 9Koo J W, Kim Y, Rozen S, et al. Enalapril accelerates remodeling of the renal interstitium after release of unilateral ureteral obstruction in rats [ J ] . J Nephrol, 2003 ( 16 ) : 203 -209.
  • 10El Chaar M, Chen J, Seshan S V, et al. Effect of combination therapy with Enalapril and the :TGF-beta antagonist 1 D 11 in unilateral ureteral obstruction [ J]. Am J Physiol Renal Physiol, 2007,292(4) :F1291-1301.

二级参考文献13

  • 1Schnaper H W, Hayashida T, Poncelet AC. It' s a Smad world : regulation of TGF-beta signaling in the kidney [ J ] . J Am Soc Nephrol, 2002 , 13 (4) :887-893.
  • 2Kliem V, Johnson R J, Alpers C E, et al. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6 nephroctomized rats [ J ] . Kidney Int, 1996,49 ( 3 ) : 666- 678.
  • 3Mahmood J, Khan F, Okada S, et al. Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis [ J ]. Kidney Int, 2006,70(9) :1591-1598.
  • 4Fujihara C K, Velho M, Malheiros D M, et al. An extremely high dose of losartan affords superior renoprotection in the remnant model[J]. Kidney Int, 2005 ,67(5) :1913-1924.
  • 5Wolf G. Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway [J]. Kidney Int, 2006 ,70(11) :1914-1919.
  • 6Derynck R, Zhang Y E. Smad-dependent and Smad-independent pathways in TGF-beta family signaling [ J ]. Nature, 2003,425(6958) :577-584.
  • 7Li J H, Zhu H J, Huang X R,et al. Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation[J]. J Am Soc Nephrol, 2002,13(6) : 1464-1472.
  • 8Kim J H, Kim B K, Moon K C, et al. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis[J]. Kidney Int, 2003,64(5) : 1715-1721.
  • 9Taal M W, Zandi-Nejad K, Weening B, et al. Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney [ J ] . Kidney Int, 2000 , 58 ( 4 ) : 1664-1676.
  • 10Noda M, Matsuo T, Fukuda R, et al. Effect of candesartan cilexetil (TCV-116 ) in rats with chronic renal failure [ J ]. Kidney Int, 1999 ,56(3) :898-909.

共引文献5

同被引文献31

  • 1Taneda S, Hudkins KL, Topouzis S, et al. Obstructive uropatby in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury[ J ]. J Am Soc Nephrol, 2003,14 (10) :2544-2555.
  • 2Fraser D, Brunskill N, lto T, et al. Long-term exposure of proximal tubular epithelial cells to glucose induces transforming growth factor-beta 1 synthesis via an autocrine PDGF loop [ J ]. Am J Pathol, 2003,163 ( 6 ) : 2565-2574.
  • 3Sommer M, Eismann U, Deuther-Conrad W, et al. Time course of cytokine mRNA expression in kidneys of rats with unilateral ureteral obstruction[J].Nephron, 2000,84( 1 ) :49-57.
  • 4Moon JA, Kim HT, Cho IS, et al. IN-1130, a novel transforming growth factor-beta type Ⅰ receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy [ J ]. Kidney Int, 2006,70(7) :1234-1243.
  • 5Nangaku M. Mechanisms of tubulointerstitial injury in the kidney : final common pathways to end-stage renal failure[ J]. Intern Med, 2004,43(1 ) :9-17.
  • 6Tang WW, Ulich TR, Lacey DL, et al. Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis [ J ]. Am J Pathol, 1996, 148 (4) : 1169-1180.
  • 7Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis [J]. Am J Physiol Renal Physiol, 2002,283(5) :F861-875.
  • 8Oda T, Jung YO, Kim HS, et al. PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction[ J]. Kidney Int, 2001, 60(2) :587-596.
  • 9Ma FY, Liu J, Kitching AR, et al. Targeting renal macrophage accumulation via c-fms kinase reduces tubular apoptosis but fails to modify progressive fibrosis in the obstructed rat kidney[ J]. Am J Physiol Renal Physiol, 2009,296 ( 1 ) : F177-185.
  • 10Tian S, Ding G, Jia R, et al. Tubulointerstitial macrophage accumulation is regulated by sequentially expressed osteopontin and macrophage colony-stimulating factor: implication for the role of atorvastatin [ J ]. Mediators Inflamm, 2006,2006 (2) : 12919.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部